Cognitive Testing on Mobile & Wearable Devices
|
|
- Kristina Perkins
- 6 years ago
- Views:
Transcription
1 Cognitive Testing on Mobile & Wearable Devices Krystyna Zaluski CANTAB Connect Prodromal Alzheimer s Background Cambridge Cognition All rights reserved Page 1
2 Overview A neuroscience digital health company - Measuring cognition accurately Validated by over 30 years of neuroscience research A measure of cognitive function in over 100 indications Trusted by the world s top pharmaceutical companies
3 Technology Platforms for Cognitive Testing Research tools Tools for clinical and research trials to detect effects of drugs and environmental changes At-home testing Cognitive tests that can be completed by participants at home High Frequency testing Frequent monitoring of cognitive ability using wearable devices In-clinic tools Cognitive assessments for clinical use that can identify those who require further investigation Neuroanalytics Consultancy We provide expertise in the design, analysis and interpretation of neuropsychological endpoints in cognitive studies and clinical trials with extensive experience using research and analytic approaches.
4 Overview CANTAB C O G N I T I V E S C I E N C E CANTAB has been used to assess over 250,000 Participants worldwide
5 Specific to Cognitive Domain
6 Specific to Neural Mechanisms Digital Biomarker Reaction Time Rapid Visual Information Processing Spatial Working Memory Episodic Memory
7 Worse performance score Sensitive to Disease State Cognitive Signature diagnosis AD MCI PD 1 0 AT_cat EF_cat EM_cat PS_cat WM_cat Attention Executive Function Episodic domain Memory Processing speed Working Memory
8 Cognition is subject to daily fluctuations
9 How to measure Cognition in the real world
10 Daily assessment across platforms and devices software enables an individual to complete an assessment on a range of mobile and wearable devices without having to visit a clinic or be helped by a health care professional. Drawing tasks to measure memory and executive function. Emotional recognition tasks to measure social cognition. N-back tasks to measure memory and attention.
11 Best Practice Approach Decisions are made with the individual in mind Patient Experience Cog Test Validity Cognitive test selection and adaptation designed with scientific rigor Large Data Sets of objective cognitive measurement and passive data points Meaningful Data
12 Validation Process Page 12
13 Developing a cognitive test for high-frequency testing N-back task activates a network of areas in the brain including frontal and parietal regions (Owen et al., 2005). There is significant variation across and within days on n-back performance, partly linked to mood and motivation (Brose et al., 2012). Rose & Ebmeier. Journal of affective disorders 90 (2006): Owen et al., Human brain mapping 25 (2005): Brose, Schmiedek, Lövdén & Lindenberger. Emotion 12 (2012): 605.
14 Phase 1: Proof of concept study in healthy volunteers Study design: 10 (4 females) aged Sensor data (heart rate, skin temperature, GSR) measured continuously between CANTAB tasks (SWM, RVP, AST, ERT) and the PANAS administered each day after 1700 Cognitive & mood assessment scheduled hourly Presentation = 600 ms ISI = 600 ms 2-back match Cormack et al, AAIC 2016
15 Baseline performance AST.correct RVPA RVP.False.Alarm age SWM.Errors linear intercept Phase 1: Detailed cognitive data 1-minute micro-tests capture meaningful across-time variation and correlate with gold-standard computerised tests. Revealed issues with device and dynamic range of the test. intercept 1 r= 0.52 linear age SWM.Errors v RVPA RVP.False. Alarm age AST.correct Cormack et al, AAIC 2016
16 Phase 2: Design refinement using web-based testing Findings from phase 1: A number of participants rapidly reached ceiling People were giving symbols names verbal recording of the stimuli, and familiarity with symbols over time Issues with the device used in the proof-of-concept: battery life, limited display, discontinuation Questions for phase 2: Change of symbol design and larger bank of symbols to reduce availability of verbal strategies Could we titrate the difficulty level without increasing the n: role of symbol complexity, timing parameters, and number of symbols Decision to use Apple iwatch
17 Phase 2: Participant Experience Refining task to increase dynamic range Converted task for web-based testing with redesigned stimuli Crowd-sourced A-B testing using Amazon m-turk Series of experiments exploring the impact of task parameters on participant performance using: Presentation time Symbol design Number of unique symbols n = 994 participants aged in total n = 88 also completed CANTAB Spatial Working memory test and CANTAB PAL (episodic memory)
18 Phase 2: Cognitive Test Validity Iterative A-B experimentation determined: Significant effect of stimulus presentation time on performance Significant impact of number of symbols in trial Symbol design (e.g. number of segments + arrangement) did not significantly impact performance r=-0.41 P<0.001 Correlations with CANTAB test significant association with SWM, but not PAL. r=-0.10 P=0.37 Confirms sensitivity to working memory performance.
19 Phase 3: In-person testing and iterative design Would the same parameters work on the watch? How would participants perform over an extended time? Is the paradigm and testing schedule tolerable? What are some of the barriers to compliance? How can we make sure that patients understand the app and the tasks? N=7 subjects over 3 weeks. Apple watch N-back testing x3 times a day
20 Cognitive Testing on Mobile & Wearable Devices CANTAB Connect Prodromal Alzheimer s Background Cambridge Cognition All rights reserved Page 20
Adaptive Design in CIAS
Adaptive Design in CIAS or If you don t know where you re going, any road will get you there Michael Sand, PhD, MPH Senior Clinical Program Leader, CNS Boehringer Ingelheim Disclosures I m an employee
More informationSchizophrenia Battery
Schizophrenia Battery Cantab Schizophrenia Battery A c c e l e r a t e t h e d e v e l o p m e n t o f s a f e a n d e f f e c t i v e m e d i c i n e s Fast, reliable and highly sensitive, the Cantab
More informationCognitive Health in the Workplace
Mild Cognitive Impairment: Uncovering the Impact on an Ageing Workforce Cognitive Health in the Workplace Dr Jenny Barnett Director, Healthcare Innovation CANTAB Corporate Health Validated by 30 years
More informationCANTAB Test descriptions by function
CANTAB Test descriptions by function The 22 tests in the CANTAB battery may be divided into the following main types of task: screening tests visual memory tests executive function, working memory and
More informationINTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME
INTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls
More informationDEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER
OVERCOMING THE CHALLENGES OF MANAGING CHRONIC DISEASES IN PERSONS WITH DEMENTIA DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER LEARNING OBJECTIVES Be familiar with the diagnostic criteria for
More informationEuropean Prevention of Alzheimer s Dementia (EPAD)
European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop
More informationDigital Biomarkers in Neurology. Digital Biomarkers Conference March 31, 2016
Digital Biomarkers in Neurology Digital Biomarkers Conference March 31, 2016 Outline Rationale Smartphones in Parkinson disease Wearables in movement disorders Future 2 Outline Rationale Smartphones in
More informationNEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P
NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P NEUROPSYCHOLOGICAL EXAMINATION A method of examining the brain; abnormal behavior is linked to
More informationCollaborating to Develop Digital Biomarkers with Passive Data Collection
Collaborating to Develop Digital Biomarkers with Passive Data Collection Iain Simpson IXICO June 2018 1 Setting of Data Collection Market evolution: biosensors and digital biomarkers Clinic Home Digital
More informationRegulatory Challenges across Dementia Subtypes European View
Regulatory Challenges across Dementia Subtypes European View Population definition including Early disease at risk Endpoints in POC studies Endpoints in pivotal trials 1 Disclaimer No CoI The opinions
More informationAn Introduction to the CBS Health Cognitive Assessment
An Introduction to the CBS Health Cognitive Assessment CBS Health is an online brain health assessment service used by leading healthcare practitioners to quantify and objectively 1 of 9 assess, monitor,
More informationBiological Risk Factors
Biological Risk Factors Ms Angelina Crea Provisional Psychologist Academic Child Psychiatry Unit Royal Children s Hospital Professor Alasdair Vance Head Academic Child Psychiatry Department of Paediatrics
More informationNeuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory
Neuropsychology and Parkinson s Disease Erin Holker, Ph.D., ABPP Neuropsychology Laboratory Parkinson s disease and cognition Parkinson s disease is not just a disorder of movement The same circuits associated
More informationWearable Devices and Smoking Cessation: What Have We Learned About Using Wearables in Behavior Change Research? Susan Murphy
Wearable Devices and Smoking Cessation: What Have We Learned About Using Wearables in Behavior Change Research? Susan Murphy 02.21.17 Much Promise for Health Behavior Change! Eating disorders (e.g., Bauer
More informationOutcome measures in neuroscience clinical trials
Neuroscience TM Outcome measures in neuroscience clinical trials Jang-Ho Cha, Head, Translational Medicine Neuroscience Novartis Institute for BioMedical Research February 2017 Outline What is our problem?
More informationTranslational Clinical Science
Translational Clinical Science Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal Children s Hospital Outline of Presentation 1. Translational Clinical
More informationTHE ICA INTEGRATED COGNITIVE ASSESSMENT TACKLING DEMENTIA WHEN IT COUNTS
THE ICA INTEGRATED COGNITIVE ASSESSMENT AI TACKLING DEMENTIA WHEN IT COUNTS 1 CONTENTS INTRODUCTION WHO WE ARE CURRENT ISSUES THE ICA BENEFITS MILESTONES MEDIA PRESCENCE 03 04 05 06 11 16 18 2 DEMENTIA
More informationMovement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree
Tracy Zitzelberger, MPH Technology & Movement: New Approaches to Understanding Change Tracy Zitzelberger, MPH Administra9ve Director Layton Aging & Alzheimer's Disease Center Oregon Center for Aging &
More informationPS3021, PS3022, PS4040
School of Psychology Important Degree Information: B.Sc./M.A. Honours The general requirements are 480 credits over a period of normally 4 years (and not more than 5 years) or part-time equivalent; the
More informationADHD in children and adolescents: examination of the association of neurological subtle signs with working memory problems
ADHD in children and adolescents: examination of the association of neurological subtle signs with working memory problems Winther, J., Aggarwal, S., Hall, N, Rennie, K., C Prakash, Williams, J., & Vance,
More informationCYGNUS: A digital brain health platform for improving dementia outcomes
CYGNUS: A digital brain health platform for improving dementia outcomes Léa Marais - IXICO Hakim Yadi - Northern Health Science Alliance www.ecygnus.com Background to Cygnus Many people with dementia are
More informationCTIS-Adverse Effects
White Paper CTIS-Adverse Effects A new Clinical Trial Information System for assessing cognitive safety in Phase I drug trials Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition 2 CTIS-Adverse
More informationERP Feature of Vigilance. Zhendong Mu
5th International Conference on Education, Management, Information and Medicine (EMIM 205) ERP Feature of Vigilance Zhendong Mu Institute of Information Technology, Jiangxi University of Technology, Nanchang,
More informationEarly intervention in Bipolar Disorder
Early intervention in Bipolar Disorder Lakshmi N. Yatham MBBS, FRCPC, MRCPsych Professor of Psychiatry, University of British Columbia, Vancouver, Canada Early Intervention in Bipolar Disorder High Risk
More informationThe future of diabetes clinical trials
The future of diabetes clinical trials Continuous glucose monitoring (CGM) for diabetes management and research Photography by Isy & Leigh Anderson and Alden Chadwick Introduction The latest technology
More informationLa cognizione sociale
15 Aprile 2015 - Firenze La cognizione sociale Chiara Cerami Divisione di Neuroscienze, Istituto Scientifico San Raffaele e Università Vita-Salute San Raffaele, Milano, Italy Theoretical Background Social
More informationpresents Approach to Dementia Care
presents The I m Still Here Approach to Dementia Care www.thehearth.org 888 422 CARE 1 2 I m Still Here : Activity Programming for Persons with Dementia Presented by Hearthstone Alzheimer Care I m Still
More informationAugmented Cognition to enhance human sensory awareness, cognitive functioning and psychic functioning: a research proposal in two phases
Augmented Cognition to enhance human sensory awareness, cognitive functioning and psychic functioning: a research proposal in two phases James Lake MD (egret4@sbcglobal.net) Overview and objectives Augmented
More informationNeuropsychology of Attention Deficit Hyperactivity Disorder (ADHD)
Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD) Ronna Fried, Ed.D. Director of Neuropsychology Clinical & Research Programs in Pediatric Psychopharmacology and Adult ADHD Massachusetts
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationMentis Cura November
Mentis Cura November 29 2012 www.mentiscura.com New Facts on Alzheimer s Death rank nr. 2-5 in western countries Fastest growing disease in: Cost Incedence Death rate People with Alzheimer s 2012 36 million
More informationConscious control of movements: increase of temporal precision in voluntarily delayed actions
Acta Neurobiol. Exp. 2001, 61: 175-179 Conscious control of movements: increase of temporal precision in voluntarily delayed actions El bieta Szel¹g 1, Krystyna Rymarczyk 1 and Ernst Pöppel 2 1 Department
More informationBeyond the Psychologist s Report. Nancy Foster, PhD Institute for Brain-Behavior Integration
Beyond the Psychologist s Report human mental processes are complex functional systems that are not localized in narrow, circumscribed areas of the brain, but take place through the participation of groups
More informationHuman Factors & User Experience LAB
Human Factors & User Experience LAB User Experience (UX) User Experience is the experience a user has when interacting with your product, service or application Through research and observation of users
More informationService Related Project. Kimberley Keegan
AN EVALUATION OF ADDENBROOKE S COGNITIVE EXAMINATION III (ACE-III) SCORES, NEUROPSYCHOLOGICAL ASSESSMENT SCORES, AND DIAGNOSIS OUTCOME WITHIN A MEMORY SERVICE. Service Related Project Kimberley Keegan
More informationTestMyBrain Consulting for RDoC Field Test Battery
TestMyBrain Consulting for RDoC Field Test Battery TABLE OF CONTENTS 1. Overview... 2 3 2. Summary of Measures... 4 6 3. TMB Anger Sensitivity... 7 4. TMB Choice Reaction Time... 12 5. TMB Delay Discounting...
More informationMSc Neuroimaging for Clinical & Cognitive Neuroscience
MSc Neuroimaging for Clinical & Cognitive Neuroscience School of Psychological Sciences Faculty of Medical & Human Sciences Module Information *Please note that this is a sample guide to modules. The exact
More informationComparing MCI Patients to Healthy Controls using Three ERP Paradigms
Comparing MCI Patients to Healthy Controls using Three ERP Paradigms Electrophysiology PIA AAIC 2015 Washington, DC Frank Knoefel, Rocío López Zunini, Vanessa Taler, Michael Breau, Lisa Sweet, Courtney
More informationChanges, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS
Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS Learning Objectives 1. Be able to describe the characteristics of brain injury 2.
More informationAPPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA
APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA The normative sample included 641 HIV-1 seronegative gay men drawn from the Multicenter AIDS Cohort Study (MACS). Subjects received a test battery consisting
More informationWhat Medicine can Learn from Marketing
What Medicine can Learn from Marketing A Consumerist Approach to Re-Branding Re-Designing & Re-Organizing Primary Care Zeev Neuwirth, MD Senior Medical Director Population Health Carolinas HealthCare System
More informationTowards scientific validated digital biomarkers measured by patient's own smart devices: cases studies from Parkinson's disease and Multiple Sclerosis
Towards scientific validated digital biomarkers measured by patient's own smart devices: cases studies from Parkinson's disease and Multiple Sclerosis Christian Gossens, PhD, MBA, Global Head Digital Biomarkers,
More informationChallenges in Developing Learning Algorithms to Personalize mhealth Treatments
Challenges in Developing Learning Algorithms to Personalize mhealth Treatments JOOLHEALTH Bar-Fit Susan A Murphy 01.16.18 HeartSteps SARA Sense 2 Stop Continually Learning Mobile Health Intervention 1)
More informationComplexity Made Simple
Complexity Made Simple Bussey-Saksida Touch Screen Chambers for Rats and Mice Tasks translate directly to well established monkey and human touch models e.g. CANTAB High throughput screening of multiple
More informationExploration of a weighed cognitive composite score for measuring decline in amnestic MCI
Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI Sarah Monsell NACC biostatistician smonsell@uw.edu October 6, 2012 Background Neuropsychological batteries used
More informationCognizanti. You Don t Join Us; We Join You. Insurance/Health & Wellness VOLUME
Cognizanti VOLUME 11 2018 Insurance/Health & Wellness You Don t Join Us; We Join You Insurance/Health & Wellness You Don t Join Us; We Join You By Steve Roberts The success of a new healthcare business
More informationWeb Usability Testing With Concurrent fnirs and Eye Tracking
Chapter 30 Web Usability Testing With Concurrent fnirs and Eye Tracking Siddharth Bhatt 1, Atahan Agrali 1, Kevin McCarthy 1, Rajneesh Suri 1, Hasan Ayaz 1,2,3 1 Drexel University, Philadelphia, PA, United
More informationTHE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME
PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence
More informationGLUCOMETER: High Level Design
Fall 2014 High Level Design 1 GLUCOMETER: High Level Design Electrical Engineers: Michael Williams, Christopher Homa, Matthew Henne Mechanical Engineer: Ish Amagashie Software Engineer: Sofyan Saputra
More informationNEUROPSYCHOMETRIC TESTS
NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract
More informationCommunication Access Features on Apple devices
Communication Access Features on Apple devices The information in this guide is correct for devices running ios 10. Devices running earlier operating systems may differ. Page 2 Page 3 Page 4 Page 5 Page
More informationClinical Trial Glossary
Clinical Trial Glossary Adverse event An unfavorable change in health that can occur during a clinical trial or study or within a certain time period after. These can range from mild (e.g., nausea) to
More informationAddressing Gaps in MS Care. November 6, :00 AM - Noon
Addressing Gaps in MS Care November 6, 2015 11:00 AM - Noon Learning Objectives Understand and confidently communicate the barriers to MS care caused by the shortage of healthcare providers with MS experience,
More informationThe Neuropsychological Impairment Scale (NIS) Self-Report Form
The Neuropsychological Impairment Scale (NIS) Self-Report Form A WPS TEST REPORT by William E O Donnell, PhD, MPH Copyright 1999 by Western Psychological Services wwwwpspublishcom Version 1110 ID Number:
More informationElectronic Care Centre for Caregivers of Patients with Alzheimer's disease
Electronic Care Centre for Caregivers of Patients with Alzheimer's disease Hippokratis Apostolidis1, Thrasyvoulos Tsiatsos1, Konstantina Karagkiozi2, Tatiana Dimitriou3, Magdalini Tsolaki3 1 Department
More informationThe Brain is Still a Mystery. National Institutes of Health 7/11/2012
Early Brain Development, Early Education, and the Development of Executive Function Skills James A. Griffin, PhD NIH/NICHD National Institutes of Health World s largest supporter of biomedical, behavioral,
More informationAlzheimer s disease dementia: a neuropsychological approach
Alzheimer s disease dementia: a neuropsychological approach Dr. Roberta Biundo, PhD Neuropsychology Coordinator at Parkinson s disease and movement disorders unit of San Camillo rehabilitation hospital
More informationWhy ICT are interesting for Frailty
Why ICT are interesting for Frailty Philippe Robert 1,2, Patrick Malléa 1,, Valeria Manera 1,, Alexandra Konig 1,, Renaud David 1,2 1 EA CoBTeK / IA, University of Nice Sophia Antipolis, France 2 Centre
More informationThe value of the CANTAB battery in evaluating
The value of the CANTAB battery in evaluating cognitive disorders in epileptic patients Abstract Epileptic process generate, depends on the cerebral region affected, a variety of neurological impairements,
More informationImproving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018
Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been
More informationIQ Tests, IQ Augmenting Technologies & How To Join Mensa
IQ Tests, IQ Augmenting Technologies & How To Join Mensa Mark Ashton Smith, Ph.D. 2015 HRP Lab, UK Chapter 2. IQ Augmenting Technologies Computerized Cognitive Training (CCT) Generally what we understand
More informationsensors ISSN
Supplementary Information OPEN ACCESS sensors ISSN 1424-8220 www.mdpi.com/journal/sensors A Review of Brain-Computer Interface Games and an Opinion Survey from Researchers, Developers and Users. Sensors
More informationNEUROCOGNITIVE, OUTCOMES IN PKU: IT S TIME TO RAISE THE BAR
NEUROCOGNITIVE, OUTCOMES IN : IT S TIME TO RAISE THE BAR KEY POINTS 1. High Phenylalanine (Phe) levels harm the brain.. Traditional therapies do not completely protect individuals with. 3. New approaches
More informationRunning head: MOOD AND COGNITION IN EVERYDAY LIFE 1. Mood Effects on Memory and Executive Control in a Real-Life Situation
Running head: MOOD AND COGNITION IN EVERYDAY LIFE 1 Mood Effects on Memory and Executive Control in a Real-Life Situation Prune Lagner 1, Matthias Kliegel 1, Louise H. Phillips 2, Andreas Ihle 1, Alexandra
More information2.0 Synopsis. Levodopa-Carbidopa Intestinal Gel M Clinical Study Report R&D/15/1285. (For National Authority Use Only)
2.0 Synopsis AbbVie Inc. Name of Study Drug: Levodopa Carbidopa Intestinal Gel (LCIG) Name of Active Ingredient: Levodopa-Carbidopa Individual Study Table Referring to Part of Dossier: Volume: Page: (For
More informationUsing the Person-based Approach. cognitive decline. Dr Alex Milton, Psychology
Using the Person-based Approach to intervention Qualitative research design: at later The RECON development Project for stages reducing cognitive decline Dr Alex Milton, Psychology Overview 1. Introduction
More informationSo, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International
So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International 1 Disclaimer The views and opinions expressed in the following PowerPoint slides are
More informationEffects of simultaneously performed cognitive and physical training in older adults
Theill et al. BMC Neuroscience 2013, 14:103 RESEARCH ARTICLE Effects of simultaneously performed cognitive and physical training in older adults Nathan Theill 1,2*, Vera Schumacher 1,2,3, Rolf Adelsberger
More informationIan McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University
Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview
More informationWhy Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills
Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills Presented by: Dr. William Mansbach CEO & Founder Mansbach Health Tools, LLC www.thebcat.com Highlights on Prevalence
More informationFundamentals of Cognitive Psychology, 3e by Ronald T. Kellogg Chapter 2. Multiple Choice
Multiple Choice 1. Which structure is not part of the visual pathway in the brain? a. occipital lobe b. optic chiasm c. lateral geniculate nucleus *d. frontal lobe Answer location: Visual Pathways 2. Which
More informationOverview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
More informationEvoked Response Potential Latency Modeling and Production Time Prediction
/ APPROVED FOR PUBLIC RELEASE Evoked Response Potential Latency Modeling and Production Time Prediction Daniel Cassenti, U.S. Army Research Laboratory ACT-R Post-Graduate Summer School / APPROVED FOR PUBLIC
More informationCapacity and Older Adults. Kenneth I. Shulman
Capacity and Older Adults Kenneth I. Shulman Increased Requests for Contemporaneous Assessments of Testamentary Capacity Increase in challenges to testamentary capacity Demographics/Economics Prevalence
More informationTable 1: Summary of measures of cognitive fatigability operationalised in existing research.
Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Candidate Mmeasures Studies Procedure Self-reported fatigue measure Key Findings The auditory As and auditory
More informationThe Neuropsychology of
The Neuropsychology of Stroke Tammy Kordes, Ph.D. Northshore Neurosciences Outline What is the Role of Neuropsychology Purpose of Neuropsychological Assessments Common Neuropsychological Disorders Assessment
More informationRecognizing and Managing the Emotional Aspects of Parkinson s. Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker
Recognizing and Managing the Emotional Aspects of Parkinson s Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker Sensory information from the one hemisphere crosses over to the other side
More informationEffect of real-time monitoring and notification
Effect of real-time monitoring and notification of smoking episodes on smoking reduction A pilot study of a novel smoking cessation app Reuven Dar ruvidar@post.tau.ac.il The Problem Need to provide highly
More informationCNADC NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011
NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011 Members: Hiroko Dodge (OHSU) Steven Ferris (NYU) Joel Kramer (UCSF) Ex Officio David Loewenstein (Miami) Po Lu (UCLA) Bruno Giordani
More informationDiscovering Breakthrough Treatments for Human Disease. Discovering Breakthrough Treatments for Human Disease
Patient Reported Outcomes in Oncology Trials Pablo Lapuerta, MD Executive Vice President and Chief Medical Officer Discovering Breakthrough Treatments for Human Disease Discovering Breakthrough Treatments
More informationWP 7: Emotion in Cognition and Action
WP 7: Emotion in Cognition and Action Lola Cañamero, UH 2 nd Plenary, May 24-27 2005, Newcastle WP7: The context Emotion in cognition & action in multi-modal interfaces? Emotion-oriented systems adapted
More informationBeyond AI: Bringing Emotional Intelligence to the Digital
Beyond AI: Bringing Emotional Intelligence to the Digital World Emotions influence every aspect of our lives how we live, work and play to the decisions we make We are surrounded by hyper-connected devices,
More informationFINAL PROGRESS REPORT
(1) Foreword (optional) (2) Table of Contents (if report is more than 10 pages) (3) List of Appendixes, Illustrations and Tables (if applicable) (4) Statement of the problem studied FINAL PROGRESS REPORT
More informationWearable Devices for Heart Disease, Sleep Apnea, and Health. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System
Wearable Devices for Heart Disease, Sleep Apnea, and Health Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System Disclosures I have no conflict of interest related to products presented
More informationTechnology Innovation Alert. N o n - i n v a s i v e D i a b e t e s M o n i t o r i n g. 16 December 31 December, Published. Granted.
Technology Innovation Alert N o n - i n v a s i v e D i a b e t e s M o n i t o r i n g 16 December 31 December, 2018 3 10 1 1 Published 10 Granted 5 Inactive 0 Start ups Companies Universities Individuals
More informationThe evox System. A medical device to measure and train the brain evox System
The A medical device to measure and train the brain 1-800-957-5520 What Is evox? The medical device to MEASURE & TRAIN brain function. Measure clinically-proven biomarkers Objectively track treatment success
More informationRevealing The Brain s Hidden Potential: Cognitive Training & Neurocognitive Plasticity. Introduction
Revealing The Brain s Hidden Potential: Cognitive Training & Neurocognitive Plasticity. Introduction Global aging poses significant burdens as age-related impairments in cognitive function affect quality
More informationUNLOCKING THE MYSTERIES OF THE BRAIN
UNLOCKING THE MYSTERIES OF THE BRAIN what is the language of the brain and how do we begin to decode it... THAT IS the challenge of the century. Today s researchers recognize that neural circuits are the
More informationNeuroTracker Published Studies & Research
NeuroTracker Published Studies & Research Evidence of Relevance in Measurement, Learning and Transfer for Learning and Learning Related Conditions NeuroTracker evolved out of a pure science approach through
More informationiage: PERSONALIZED TECHNOLOGIES FOR FACILITATING HEALTH, WELLNESS AND SUCCESSFUL AGING
iage: PERSONALIZED TECHNOLOGIES FOR FACILITATING HEALTH, WELLNESS AND SUCCESSFUL AGING Binh Q. Tran, Ph.D. Director, HomeCare & Telerehabilitation Technology Center Department of Biomedical Engineering
More informationPractical Application using Behavior-Based Ergonomics Therapy (BBET) Program
Award-Winning Neuroscience Approach to Alzheimer s / Dementia Care of Residents Objectives 1. Discuss the research basis for cognitive ergonomics and neuroscience in Alzheimer s disease / dementia. 2.
More informationCancer and Cognitive Functioning: Strategies for Improvement
Cancer and Cognitive Functioning: Strategies for Improvement Myron Goldberg, Ph.D., ABPP-CN Clinical Neuropsychologist Director, Neuro-Rehabilitation Program Department of Rehabilitation Medicine University
More informationAlzheimer s Disease Research
PRA INSIGHTS REPORT Alzheimer s Disease Research JULY 2017 Page 01 of 9 TABLE OF CONTENTS Introduction Methodology Summary Question One: Demographics Question Two: The Foremost Challenge in Neuroscience
More informationWhere No Interface Has Gone Before: What Can the Phaser Teach Us About Label Usage in HCI?
Where No Interface Has Gone Before: What Can the Phaser Teach Us About Label Usage in HCI? Franklin P. Tamborello, II Phillip H. Chung Michael D. Byrne Rice University Department of Psychology 61 S. Main,
More informationKNOWLEDGE VALORIZATION
KNOWLEDGE VALORIZATION The goal of this valorisation chapter is to describe how the knowledge resulting from the research in this dissertation can be made valuable for clinical and social use. This dissertation
More informationRegional Grey Matter Atrophy is associated with Social Cognition impairment in Progressive Multiple Sclerosis (MS).
Escuela de Medicina Regional Grey Matter Atrophy is associated with Social Cognition impairment in Progressive Multiple Sclerosis (MS). Escuela de Medicina Tomas Labbe(1), Ethel Ciampi(2), Juan Pablo Cruz(3),
More informationAssessing cognitive function after stroke. Glyn Humphreys
Assessing cognitive function after stroke Glyn Humphreys (glyn.humphreys@psy.ox.ac.uk) Write down 3 important cognitive problems after stroke What things are important to detect? OCS Impairment incidences
More informationNeuro Q no.2 = Neuro Quotient
TRANSDISCIPLINARY RESEARCH SEMINAR CLINICAL SCIENCE RESEARCH PLATFORM 27 July 2010 School of Medical Sciences USM Health Campus Neuro Q no.2 = Neuro Quotient Dr.Muzaimi Mustapha Department of Neurosciences
More information